Lisata Therapeutics Stock (NASDAQ: LSTA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 13.162K |
Day Range | - - - |
52 Wk Range | 1.950 - 4.533 |
Market Cap | $23.342M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.24% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lisata Therapeutics (NASDAQ: LSTA) through any online brokerage.
Other companies in Lisata Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), T2 Biosystems (NASDAQ:TTOO), Evaxion Biotech (NASDAQ:EVAX) and Lumos Pharma (NASDAQ:LUMO).
The latest price target for Lisata Therapeutics (NASDAQ: LSTA) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 15.00 expecting LSTA to rise to within 12 months (a possible 433.81% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Lisata Therapeutics (NASDAQ: LSTA) is $2.81 last updated April 24, 2024 at 8:14 AM EDT.
There are no upcoming dividends for Lisata Therapeutics.
Lisata Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Lisata Therapeutics.
Lisata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.